49 related articles for article (PubMed ID: 9592244)
1. [FLT3/FLK2: a novel member of tyrosine kinase receptor family].
Wen GY; He FC; Su ZZ
Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):165-7. PubMed ID: 9592244
[No Abstract] [Full Text] [Related]
2. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
3. CD135.
Del Zotto G; Luchetti F; Zamai L
J Biol Regul Homeost Agents; 2001; 15(1):103-6. PubMed ID: 11388739
[No Abstract] [Full Text] [Related]
4. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene.
Lyman SD; James L; Zappone J; Sleath PR; Beckmann MP; Bird T
Oncogene; 1993 Apr; 8(4):815-22. PubMed ID: 7681159
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.
Kiyoi H; Ohno R; Ueda R; Saito H; Naoe T
Oncogene; 2002 Apr; 21(16):2555-63. PubMed ID: 11971190
[TBL] [Abstract][Full Text] [Related]
6. Early plasma membrane events occurring in ultraviolet-B-induced apoptosis.
Albanese J; Dainiak N
Stem Cells; 1997; 15 Suppl 2():49-57. PubMed ID: 9368286
[TBL] [Abstract][Full Text] [Related]
7. The expression of FMS, KIT and FLT3 in hematopoietic malignancies.
Birg F; Rosnet O; Carbuccia N; Birnbaum D
Leuk Lymphoma; 1994 Apr; 13(3-4):223-7. PubMed ID: 7519507
[TBL] [Abstract][Full Text] [Related]
8. Optimizing hematopoietic stem cell engraftment: a novel role for thrombopoietin.
Verfaillie CM
J Clin Invest; 2002 Aug; 110(3):303-4. PubMed ID: 12163447
[No Abstract] [Full Text] [Related]
9. Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots.
Savvides SN; Boone T; Andrew Karplus P
Nat Struct Biol; 2000 Jun; 7(6):486-91. PubMed ID: 10881197
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic receptor tyrosine kinase in leukemia.
Mizuki M; Ueda S; Matsumura I; Ishiko J; Schwäble J; Serve H; Kanakura Y
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):907-22. PubMed ID: 14656048
[TBL] [Abstract][Full Text] [Related]
11. [Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches].
Spiekermann K; Hiddemann W; Schnittger S
Dtsch Med Wochenschr; 2005 Apr; 130(16):1020-5. PubMed ID: 15830315
[No Abstract] [Full Text] [Related]
12. The role of FLT3 in haematopoietic malignancies.
Stirewalt DL; Radich JP
Nat Rev Cancer; 2003 Sep; 3(9):650-65. PubMed ID: 12951584
[TBL] [Abstract][Full Text] [Related]
13. FLT3 inhibition as tailored therapy for acute myeloid leukemia.
Martinelli G; Piccaluga PP; Lo Coco F
Haematologica; 2003 Jan; 88(1):4-8. PubMed ID: 12551818
[No Abstract] [Full Text] [Related]
14. Expression and function of Flt3/flk2 in human tumor cell lines.
Serve H; Flesch K; Serve S; Fenski R; Berdel WE
Int J Oncol; 1999 Apr; 14(4):765-70. PubMed ID: 10087327
[TBL] [Abstract][Full Text] [Related]
15. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain.
Griffith J; Black J; Faerman C; Swenson L; Wynn M; Lu F; Lippke J; Saxena K
Mol Cell; 2004 Jan; 13(2):169-78. PubMed ID: 14759363
[TBL] [Abstract][Full Text] [Related]
16. Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
O'Farrell AM; Yuen HA; Smolich B; Hannah AL; Louie SG; Hong W; Stopeck AT; Silverman LR; Lancet JE; Karp JE; Albitar M; Cherrington JM; Giles FJ
Leuk Res; 2004 Jul; 28(7):679-89. PubMed ID: 15158089
[TBL] [Abstract][Full Text] [Related]
17. Localization of the human stem cell tyrosine kinase-1 gene (FLT3) to 13q12-->q13.
Carow CE; Kim E; Hawkins AL; Webb HD; Griffin CA; Jabs EW; Civin CI; Small D
Cytogenet Cell Genet; 1995; 70(3-4):255-7. PubMed ID: 7789184
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a functional murine FLT3 isoform produced by exon skipping.
Lavagna C; Marchetto S; Birnbaum D; Rosnet O
J Biol Chem; 1995 Feb; 270(7):3165-71. PubMed ID: 7531700
[TBL] [Abstract][Full Text] [Related]
19. Direct display of hematopoietic tyrosine kinase receptor expression profiles in KG1 cells by PCR using degenerate primers.
Visser M; Sonneveld RD; Willemze R; Landegent JE
Leukemia; 1996 Aug; 10(8):1395-9. PubMed ID: 8709651
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors.
Mackarehtschian K; Hardin JD; Moore KA; Boast S; Goff SP; Lemischka IR
Immunity; 1995 Jul; 3(1):147-61. PubMed ID: 7621074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
